坏死性凋亡在细菌与宿主相互作用中的机制研究进展

坏死性凋亡(necroptosis)是由受体相互作用蛋白(receptor-interacting protein/receptor-interacting protein kinase,RIP/RIPK)调控的调节性细胞死亡(regulated cell death,RCD)方式之一,可分为依赖RIPK1的经典途径和不依赖RIPK1的非经典途径。RIPK3和混合系列激酶结构域样蛋白(mixed lineage kinase domain-like,MLKL)通过以上两种途径被有序激活,最终诱导细胞发生坏死性凋亡。病原微生物感染过程中会发生多种形式的细胞死亡,其结局高度依赖宿主受感染细胞的命运,一方面细菌毒力因子导致宿主细胞发生坏死性凋亡;另一方面坏死性凋亡也是宿主免疫防御的重要方式。深入探讨坏死性凋亡在细菌与宿主相互作用中的机制对揭示感染性疾病的发生和发展具有重要意义。     

程序性坏死相关蛋白在炎症性肠病中的作用研究进展

程序性坏死(Necroptosis)是一种新近发现受调控的细胞坏死,主要依赖于激活后的RIPK1/RIPK3/MLKL等蛋白形成级联复合体并最终导致细胞呈现坏死样特征.越来越多的研究显示,程序性坏死参与了多种炎症性疾病,特别是炎症性肠病的发生发展.对疾病产生机制的研究有助于疾病的预防与治疗,因此该文对程序性坏死及其关键...     

坏死性凋亡:一种新的细胞死亡方式

传统上,细胞死亡分为凋亡和坏死两类。而近年来越来越多的研究表明坏死性凋亡是一种不同于凋亡和坏死的新型细胞死亡途径,在多种疾病模型中发挥着重要作用。本文对坏死性凋亡的产生机制、坏死性凋亡同凋亡和坏死的区别及其在疾病和药物靶点发现中的作用进行综述,以利于加深对不同细胞死亡方式的认识并促进相关新药的研发。     

坏死性凋亡在肝缺血再灌注损伤中作用的研究进展

坏死性凋亡是一种精细调控的坏死形式,由死亡受体与配体结合介导,在其发生过程中,受体相互作用蛋白家族(receptor-interacting proteins,RIPs)和混合谱系激酶结构域样蛋白(mixed lineage kinase domain-like protein,MLKL)发挥关键作用。越来越多的研究证明,坏死性凋亡引起的细胞损伤和炎症反应在肝脏缺血再灌注损伤(hepatic ischemia-reperfusion injury,HIRI)中发挥重要作用。本文综述了坏死性凋亡的机制及其在HIRI中的作用,并对坏死性凋亡的抑制剂作简要总结。     

关于TRAIL对凋亡的作用

凋亡,即程序性细胞死亡,是允许多细胞动物严格调控细胞生长,防止癌症、免疫缺陷及自身反应性等病理过程的一种关键机制。在哺乳动物细胞中,凋亡可通过两个主要途径起始：一个与死亡受体的参与有关,另一个则与线粒体释放细胞色素c有关。线粒体途径既可由外部信号也可由内部信号如DNA损伤所触发。Bcl-2家族的促凋亡(pro—apoptotic)和抗凋亡(anti—apoptotic)成员可聚集于线粒体表     

Parkin调控凋亡、坏死性凋亡和焦亡的研究进展

细胞的死亡有多种形式,包括凋亡、坏死性凋亡、焦亡等,各具有独特的分子特征,发挥着不同的功能.近年来,对各种死亡形式的功能和机制研究不断深入,围绕着细胞死亡途径的特征分子及其调控取得重要进展.Parkin作为E3泛素连接酶,通过其对底物的泛素化修饰,而发挥多种生物学功能.除了其被熟知的介导线粒体自噬途径之外,近年的研究还...     

哺乳动物细胞凋亡中的功能元件研究进展

在哺乳动物细胞中,程序性细胞死亡（ＰＣＤ）的功能元件包括死亡受体、适配体蛋白、效应元件及调节元件。凋亡信号由适配体蛋白传导至效应元件－Ａｓｐ特异性半胱氨酸蛋白酶（Ｃａｓｐａｓｅ）,活化的Ｃａｓｐａｓｅ水解一系列关键底物,最终导致细胞解体。Ｂｃｌ－２家族、ＩＡＰｓ家族、ＡＲＣ和ＦＬＩＰｓ等蛋白因子通过与适配体蛋白及Ｃａｓｐａｓｅ的相互作用来调控ＰＣＤ进程。     

细胞自噬与凋亡的交互作用

细胞自唾又称Ⅱ型程序性细胞死亡,参与了多种疾病的发生和发展。自唆与凋亡之间存在着复杂的交互调控——二者能被多种应激刺激共同激活、共享多个调节分子,甚至互相协调转化等。全面深入研究自噬与凋亡之间的交互作用机制,将为肿瘤等疾病的认知及治疗带来突破性进展。     

肝硬化疾病与支链氨基酸应用研究进展

蛋白质-营养不良是肝硬化病人最常见的并发症之一。肝脏作为蛋白质、脂类和糖代谢的主要器官,病变后的代谢紊乱随之而来。不适宜的蛋白质-能量摄入只会加重病情最后发生肝性脑病等危及生命的严重后果。因此,肝硬化病人的营养管理显得尤为重要,氨基酸的适宜供给无疑是营养治疗的重中之重。已知支链氨基酸能通过刺激肝细胞合成、减少肝损伤后的分解代谢等诸多方式改善营养状况,但是各种试验结果仍存在争议。最佳适宜量究竟多大,安全性范围的设定以及确切的保护机理等问题仍待进一步深入研究。     

程序性细胞坏死及其信号通路

细胞凋亡曾被认为是唯一的程序性细胞死亡方式,而坏死是不受信号调控的。但越来越多的证据表明,某些类型的细胞坏死也可受到信号分子的调控,称为程序性细胞坏死,并发现其在免疫功能调控、炎症、感染性疾病中发挥重要作用。本文对程序性细胞坏死的形态特征和信号转导通路及其与免疫系统功能、炎症反应的关系等方面的研究进展作一综述。     

血管内皮细胞生长因子促进成骨作用的研究进展

骨组织的生长和血供密切相关 ,血管内皮细胞生长因子 (VEGF)被公认为是诱导血管生成作用最强的一种细胞因子 ,其自身也和骨形成有着直接的关系。通过对VEGF及其受体分子结构、其在骨发育和骨损伤修复中所起作用、以及目前常见应用方式的相关研究作一系统性回顾 ;阐述了VEGF在软骨内成骨、膜内成骨过程中所起的促进作用 ,对成骨细胞和破骨细胞的积极影响 ,增强其表达的相关条件 ,以及各应用方式的利弊 ;从而展示了VEGF在骨缺损修复中的良好的前景。     

Necroptosis, necrostatins and tissue injury

Cell death is an integral part of the life of an organism being necessary for the maintenance of organs and tissues. If, however, cell death is allowed to proceed unrestricted, tissue damage and degenerative disease may ensue. Until recently, three morphologically distinct types of cell death were recognized, apoptosis (type I), autophagy (type II) and necrosis (type III). Apoptosis is a highly regulated, genetically determined mechanism designed to dismantle cells systematically (e.g. cells that are no longer functionally viable), via protease (caspase) action, and maintain homeostasis. Autophagy is responsible for the degradation of cytoplasmic material, e.g. proteins and organelles, through autophagosome formation and subsequent proteolytic degradation by lysosomes, and is normally considered in the context of survival although it is sometimes associated with cell death. Necrosis was formerly considered to be an accidental, unregulated form of cell death resulting from excessive stress, although it has been suggested that this is an over-simplistic view as necrosis may under certain circumstances involve the mobilization of specific transduction mechanisms. Indeed, recently, an alternative death pathway, termed necroptosis, was delineated and proposed as a form of 'programmed necrosis'. Identified with the aid of specific inhibitors called necrostatins, necroptosis shares characteristics with both necrosis and apoptosis. Necroptosis involves Fas/tumour necrosis factor-α death domain receptor activation and inhibition of receptor-interacting protein I kinase, and it has been suggested that it may contribute to the development of neurological and myocardial diseases. Significantly, necrostatin-like drugs have been mooted as possible future therapeutic agents for the treatment of degenerative conditions.     

乳腺癌免疫治疗：生物标志物、药物及疫苗

虽然近年来肿瘤的治疗取得较大进展,乳腺癌依旧是威胁女性健康的主要杀手。近年来,乳腺癌相关的免疫治疗取得较大进展,肿瘤浸润淋巴细胞(TILs)、程序性死亡受体 1(PD 1)及其配体PD L1、肿瘤突变负荷等肿瘤标志物对乳腺癌免疫治疗具有预测作用,并与乳腺癌的预后相关。免疫检查点抑制剂,例如PD-1/PD-L1及细胞毒性T淋巴细胞抗原4(CTLA 4)抑制剂在乳腺癌中取得极大进展,各期临床试验结果显示不同的效用。肿瘤疫苗的使用为乳腺癌免疫治疗的另一途径,虽然部分疫苗在临床试验中取得较好成效,但绝大多数仍需深入研究,乳腺癌免疫治疗之途仅为开端,依旧需要大量研究。本文简要介绍了乳腺癌免疫治疗相关的生物标志物、免疫检查点抑制剂以及肿瘤疫苗的研究进展。     

Necroptosis protects against exacerbation of acute pancreatitis

The sensing of various extrinsic stimuli triggers the receptor-interacting protein kinase-3 (RIPK3)-mediated signaling pathway, which leads to mixed-lineage kinase-like (MLKL) phosphorylation followed by necroptosis. Although necroptosis is a form of cell death and is involved in inflammatory conditions, the roles of necroptosis in acute pancreatitis (AP) remain unclear. In the current study, we administered caerulein to Ripk3- or Mlkl-deficient mice (Ripk3^−/− or Mlkl^−/− mice, respectively) and assessed the roles of necroptosis in AP. We found that Ripk3^−/− mice had significantly more severe pancreatic edema and inflammation associated with macrophage and neutrophil infiltration than control mice. Consistently, Mlkl^−/− mice were more susceptible to caerulein-induced AP, which occurred in a time- and dose-dependent manner, than control mice. Mlkl^−/− mice exhibit weight loss, edematous pancreatitis, necrotizing pancreatitis, and acinar cell dedifferentiation in response to tissue damage. Genetic deletion of Mlkl resulted in downregulation of the antiapoptotic genes Bclxl and Cflar in association with increases in the numbers of apoptotic cells, as detected by TUNEL assay. These findings suggest that RIPK3 and MLKL-mediated necroptosis exerts protective effects in AP and caution against the use of necroptosis inhibitors for AP treatment.Subject terms: Acute pancreatitis, Experimental models of disease     

The role of Ubiquitination in Apoptosis and Necroptosis

Cell death pathways have evolved to maintain tissue homoeostasis and eliminate potentially harmful cells from within an organism, such as cells with damaged DNA that could lead to cancer. Apoptosis, known to eliminate cells in a predominantly non-inflammatory manner, is controlled by two main branches, the intrinsic and extrinsic apoptotic pathways. While the intrinsic pathway is regulated by the Bcl-2 family members, the extrinsic pathway is controlled by the Death receptors, members of the tumour necrosis factor (TNF) receptor superfamily. Death receptors can also activate a pro-inflammatory type of cell death, necroptosis, when Caspase-8 is inhibited. Apoptotic pathways are known to be tightly regulated by post-translational modifications, especially by ubiquitination. This review discusses research on ubiquitination-mediated regulation of apoptotic signalling. Additionally, the emerging importance of ubiquitination in regulating necroptosis is discussed.Subject terms: Protein-protein interaction networks, Deubiquitylating enzymes, Ubiquitin ligases, Ubiquitylation